NYSE, WPI - Watson Pharmaceuticals
Watson Pharmaceuticals, Inc. (?Watson?, the ?Company? ?we?, ?us? or ?our?) is a
leading specialty pharmaceutical company engaged in the development,
manufacture, marketing, sale and distribution of brand and generic (off-patent)
pharmaceutical products. Our operations are based predominantly in the United
States (U.S.) and India, with our key commercial market being the U.S. As of
December 31, 2007, we marketed 150 generic pharmaceutical product families and
27 brand pharmaceutical product families through our Generic and Brand
Divisions, respectively, and distributed approximately 8,000 stock-keeping units
(?SKUs?) through our Distribution Division.
Our principal executive offices are located at 311 Bonnie Circle, Corona,
California, 92880. Our Internet website address is www.watson.com. We do not
intend this website address to be an active link or to otherwise incorporate by
reference the contents of the website into this report. ...
Read SEC Filing on NASDAQ.com »